Data as of Aug 29
| +0.21 / +0.13%|
The 18 analysts offering 12-month price forecasts for Jazz Pharmaceuticals PLC have a median target of 185.50, with a high estimate of 215.00 and a low estimate of 130.00. The median estimate represents a +13.86% increase from the last price of 162.92.
The current consensus among 19 polled investment analysts is to Buy stock in Jazz Pharmaceuticals PLC. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.